Company Filing History:
Years Active: 1998
Title: Marisa Wick - Innovator in Gene Therapy
Introduction
Marisa Wick is a prominent inventor based in Deutschland, DE. She has made significant contributions to the field of gene therapy, particularly through her innovative work on promoter sequences for gene expression regulation.
Latest Patents
Marisa Wick holds a patent for "Cell-specific gene therapy using as promoter novel promoters for tissue." This invention relates to promoter sequences for a gene comprising a tissue inhibitor of metalloproteinase-3 (TIMP-3). The TIMP-3 inhibitor is notably found in macrophages, synovial cells, and connective tissue cells. The patent also encompasses cell-specific gene therapy, where the expression of a gene in a tissue is regulated by the aforementioned promoter sequence operationally coupled to the gene. Additionally, the promoter may be utilized in various diagnostic methods. She has 1 patent to her name.
Career Highlights
Marisa Wick is associated with Hoechst Aktiengesellschaft, where she has been able to apply her expertise in gene therapy. Her work has been instrumental in advancing the understanding and application of gene regulation in medical therapies.
Collaborations
Throughout her career, Marisa has collaborated with notable colleagues, including Hans-Harald Sedlacek and Rolf Muller. These collaborations have further enriched her research and contributions to the field.
Conclusion
Marisa Wick is a trailblazer in the realm of gene therapy, with her innovative patent showcasing the potential for targeted gene regulation. Her work continues to influence advancements in medical science and therapeutic applications.